CD4+ effector T cells accelerate Alzheimer’s disease in mice

CD4+ effector T cells accelerate Alzheimer’s disease in mice

Abstract Background Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterized by pathological deposition of misfolded self-protein amyloid beta (Aβ) which in kind facilitates tau aggregation and neurodegeneration. Neuroinflammation is accepted as a key disease driver caused...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Jatin Machhi, Pravin Yeapuri, Yaman Lu, Emma Foster, Rupesh Chikhale, Jonathan Herskovitz, Krista L. Namminga, Katherine E. Olson, Mai Mohamed Abdelmoaty, Ju Gao, Rolen M. Quadros, Tomomi Kiyota, Liang Jingjing, Bhavesh D. Kevadiya, Xinglong Wang, Yutong Liu, Larisa Y. Poluektova, Channabasavaiah B. Gurumurthy, R. Lee Mosley, Howard E. Gendelman
Format: article
Langue:EN
Publié: BMC 2021
Sujets:
Alzheimer’s disease (AD)
Amyloid beta (Aβ)
T cell
Effector T cell (Teff)
Regulatory T cell (Treg)
APP/PS1 transgenic mice
Neurology. Diseases of the nervous system
RC346-429
Accès en ligne:https://doaj.org/article/9566142d7b6b497fa6e8c5d16550ee05
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Internet

https://doaj.org/article/9566142d7b6b497fa6e8c5d16550ee05

Documents similaires